Top Dow Stocks Year-to-Date (December 2018)

Chart of Top Dow Stocks (December 2018) - Merck (MRK), Microsoft, (MSFT), UnitedHealth (UNH), Cisco (CSCO), Visa (V)

As markets (including the Dow) began December 2018 on a highly positive note, it’s fitting to present the newest edition of our Top Dow Stocks for this year so far. We’ve already just given you the best of the tiny stocks in our Top Penny Stocks to Watch in December 2018 article. Now it’s time for the best of the beasts in this list of top-performing mega-cap companies from the Dow Jones Industrial Average (DJIA) index.

Without further ado, here’s the list of companies and their primary areas of business:

  • Merck & Co., Inc. (MRK) – Pharmaceuticals
  • Microsoft Corp. (MSFT) – Software
  • UnitedHealth Group Inc. (UNH) – Healthcare Plans
  • Cisco Systems, Inc. (CSCO) – Networking/Telecommunications Equipment
  • Visa Inc. (V) – Credit Services

The chart above shows the current price and year-to-date percentage performance (as of the 12/3/2018 market close) for each of these five top performers. As we noted last month, healthcare-related companies have been doing particularly well of late. So, Merck and UnitedHealth are no surprise. As we also noted recently, Microsoft has been rivaling Apple for the title of largest public company. In addition, Cisco has been making a big comeback, and should be poised for further gains. And finally, credit card stocks like Visa have also been ‘charging’ forward.

Runners-up on this list include top Dow performers like Pfizer (PFE), Nike (NKE), and Boeing (BA).

As we look forward to a potential end-of-year rally in December, all of these very strong companies and stocks have a solid opportunity to make significantly further gains going into 2019.


IMPORTANT: The information above should not be construed as investment advice and should not be considered as a solicitation to buy or sell securities. Past performance is not indicative of future results. Trading and investing in the financial markets involves substantial risk of loss, and may not be suitable for all investors.

You may also like...